Image For Activity Cover
Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities (JACC: CardioOncology State-of-the-Art Review October 2023)
Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review



Cancer treatment-induced cardiotoxicities are an ongoing concern throughout the cancer care continuum from treatment initiation to survivorship. Several ‘standard-of-care’ primary, secondary, and tertiary prevention strategies are available to prevent the development or further progression of cancer treatment-induced cardiotoxicities and their risk factors. Despite exercise’s established benefits on the cardiovascular system, it has not been widely adopted as a non-pharmacological cardioprotective strategy within cardio-oncology care. Within this State-of-the-Art Review we discuss cancer treatment-induced heart failure and coronary artery disease as two notable manifestations of cardiotoxicity with major health impacts, review the existing evidence supporting the role of exercise in preventing and managing these sequelae in at-risk and affected individuals living after a cancer diagnosis, and propose considerations for implementing exercise-based services in cardio-oncology practice.

JACC CardioOncology Editor-in-Chief and CME Editor
Bonnie Ky, MD, MSCE, FACC

Kelvin N.V. Bush, MD, FACC

Important Dates

Date of Release: October 17, 2023
Term of Approval/Date of CME/MOC Expiration: October 16, 2024

Availability: On-Demand
Expires on Oct 16, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By